Abbott Media News Today

Abbott (NYSE: ABT) today announced that the U.S. Food and Drug Administration (FDA) has approved the Esprit™ BTK Everolimus Eluting Resorbable Scaffold System (Esprit BTK System), a breakthrough innovation for people with chronic limb-threatening ischemia (CLTI) below-the-knee (BTK). The Esprit BTK System is ...

New Study Shows Mixed Reality Technology for Blood Donation From Abbott ...

Diana Isaacs, PharmD, and Natalie Bellini, DNP, provide a breakdown of the latest news in diabetes management, including FDA clearance of a new insulin pump and a major acquisition within the diabetes world.

Abbott, Real Madrid and the Real Madrid Foundation launch 'Beat Malnutrition' campaign as part of a sustained collaboration urging communities to work together to reduce malnutritionCampaign will supply

AbbottNew efforts focus on research infrastructure, continued training of diverse clinical research personnel and improved diversity within Abbott's own clinical trialsAbbott's Diversity in Clinical Trials

Mixed reality offers donors an innovative, immersive digital experience while giving bloodThe Abbott technology is one of the first-ever, consumer-focused mixed reality applications completely controlled

Abbott's FreeStyle Libre honored as the "best of the best" since 1970 during the Prix Galien Golden Jubilee AwardsRevolutionary FreeStyle Libre technology has transformed the lives of approximately 4.5

Abbott today announced that UnitedHealthcare (UHC), the largest private health insurance company in the United States, has updated its ‘Implanted Electrical Stimulator for Spinal Cord’ medical policy to expand patient access to Abbott’s dorsal root ganglion (DRG) neurostimulation devices for people suffering from ...

ABBOTT PARK, Ill., January 19, 2021 /3BL Media/ -- Abbott (NYSE: ABT) has received 510(k) clearance for the first rapid handheld traumatic brain injury (TBI) blood test, which will help clinicians assess individuals with suspected mild TBIs, including concussions. The test will run on Abbotts handheld i-STAT™ Alinity™ platform. Tests results are available within 15 minutes after plasma is placed in the test cartridge. TBIs, including concussions, are an alteration in brain function caused...